We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

237 hedge funds and large institutions have $6.73B invested in Alnylam Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 106 increasing their positions, 59 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 22

80% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 59

33% more call options, than puts

Call options by funds: $84.9M | Put options by funds: $63.7M

20% more funds holding in top 10

Funds holding in top 10: 10 → 12 (+2)

20% more capital invested

Capital invested by funds: $5.62B → $6.73B (+$1.11B)

10% more funds holding

Funds holding: 215 → 237 (+22)

Holders
237
Holders Change
+22
Holders Change %
+10.23%
% of All Funds
6.32%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.32%
New
47
Increased
106
Reduced
59
Closed
22
Calls
$84.9M
Puts
$63.7M
Net Calls
+$21.2M
Net Calls Change
+$5.1M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$151M
2
Capital World Investors
Capital World Investors
California
+$119M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$104M
4
Artisan Partners
Artisan Partners
Wisconsin
+$80.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$61.5M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$103M
2
AWG
Alpha Wave Global
New York
-$50.3M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$20.5M
4
EA
Emerald Advisers
Pennsylvania
-$20.2M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
226
Next Financial Group
Texas
$15K – – –
CTC
227
Central Trust Company
Missouri
$14K – – –
IMS
228
Index Management Solutions
Pennsylvania
$14K +$13.4K +132 New
WTB
229
Washington Trust Bank
Washington
$10K +$2.53K +25 +33%
CIM
230
CenturyLink Investment Management
Colorado
$7K +$6.38K +63 New
Creative Planning
231
Creative Planning
Kansas
$7K +$7.09K +70 New
US Bancorp
232
US Bancorp
Minnesota
$4K -$25.6K -253 -87%
BBHC
233
Brown Brothers Harriman & Co
New York
$4K – – –
MFS
234
MSI Financial Services
Massachusetts
$4K +$4.05K +40 New
QT
235
Quantbot Technologies
New York
$1K -$112K -1,104 -99%
Manulife (Manufacturers Life Insurance)
236
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$227 – – –
CIM
237
Cambria Investment Management
California
$2 +$1.82K +18 New
CCM
238
Cadian Capital Management
New York
– -$12.6M -130,243 Closed
N
239
Nuveen
North Carolina
– -$10.6M -109,216 Closed
MSA
240
Mason Street Advisors
Wisconsin
– -$5.69M -58,620 Closed
OAM
241
Oxford Asset Management
United Kingdom
– -$4.89M -49,594 Closed
OM
242
Opaleye Management
Massachusetts
– -$2.82M -29,100 Closed
LI
243
LMCG Investments
Massachusetts
– -$1.61M -16,566 Closed
WMSA
244
Weiss Multi-Strategy Advisers
New York
– -$1.07M -11,000 Closed
NI
245
Numeric Investors
Massachusetts
– -$1.04M -10,700 Closed
CCIA
246
Campbell & Co Investment Adviser
Maryland
– -$645K -6,652 Closed
Connor, Clark & Lunn Investment Management (CC&L)
247
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$495K -5,100 Closed
Tudor Investment Corp
248
Tudor Investment Corp
Connecticut
– -$343K -3,540 Closed
QIM
249
Quantitative Investment Management
Virginia
– -$320K -3,300 Closed
FMT
250
First Mercantile Trust
Tennessee
– -$286K -2,947 Closed
7 8 9
10
11

ALNY Hedge Fund Activity: Q1 2015 in Review

237 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2015, worth a combined $6.73B — up 20% from $5.62B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ALNY positions and 22 closed out — a net gain of 25 holders — while 106 added to existing stakes and 59 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $151M. The largest seller was Franklin Resources, cutting an estimated $103M.

  • 237 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2015, up from 215 in Q4 2014.
  • Funds reported $6.73B of Alnylam Pharmaceuticals stock for Q1 2015, up 20% quarter-over-quarter.
  • 47 funds opened new Alnylam Pharmaceuticals positions in Q1 2015 and 22 closed out, a net change of +25 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2015 was Wellington Management Group, an estimated $151M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2015 was Franklin Resources, an estimated $103M sold.

Based on aggregated 13F filings for Q1 2015.